Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
UltraSOL Curcumin
- Development stage
- Unknown
- Lead developer
- OmniActive Health Technologies
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
UltraSOL Curcumin is a proprietary, water-dispersible curcumin formulation developed by OmniActive Health Technologies using the UltraSOL Nutrient Delivery System. This technology significantly enhances the bioavailability of curcuminoids—the active polyphenolic compounds extracted from *Curcuma longa* (turmeric)—by converting lipophilic nutrients into a water-dispersible form. Marketed under brand names such as CurcuWIN and CurcuWIN Ultra+, the formulation is designed to overcome the poor absorption typically associated with standard curcumin. It has been clinically studied for its applications in sports nutrition, specifically for reducing exercise-induced muscle damage and improving recovery, as well as for supporting joint health in conditions like osteoarthritis, enhancing endothelial function, and managing systemic inflammation.
- Brand names
- CurcuWINCurcuWIN Ultra+
- Other names
- curcumincurcuminoidsturmeric extract
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NF-κBIL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on UltraSOL Curcumin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UltraSOL Curcumin.